Search - tctmd.com

Displaying 821 - 840 of 1350

Sort: Relevancy | Date

Presentation Cardiovascular Interventions 2018

Show me the Data: Key Clinical Trials of 2018

Presenter: Ehtisham Mahmud

October 26, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Opinion Editor's Corner TCT 2018

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Shelley Wood

October 12, 2018

News Daily News

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

Caitlin E. Cox

October 04, 2018

News Daily News

Structural Heart Disease Imagers Call for Greater Recognition, Focused Training

Yael L. Maxwell

October 03, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

Shelley Wood

October 02, 2018

News Daily News

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

Todd Neale

October 01, 2018

News Conference News TCT 2018

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

TCT Daily Staff

September 28, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Conference News TCT 2018

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

Yael L. Maxwell

September 25, 2018

Presentation TCT 2018

The Watch TAVR Trial: Rationale, Design and Status

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Samir R. Kapadia

September 24, 2018

Presentation TCT 2018

A Patient With Atrial Fibrillation, Cryptogenic Stroke, and PFO: Watchman Despite OAC?

Presenter: Zahid Amin, Robert J. Sommer, Peter C. Block, John P. Breinholt, Craig E Fleishman, Jan Kovac, Harsimran Sachdeva Singh, Christian Spies

September 24, 2018

Presentation TCT 2018

Addressing the Hurdles: Emerging Devices and Novel Valve Designs

Presenter: Howard C. Herrmann, Vinod H. Thourani

September 24, 2018

Presentation TCT 2018

The LAMPOON Procedure: Description and Clinical Outcomes

Presenter: James B. Hermiller Jr, Wilson Y. Szeto, Robert J. Lederman

September 24, 2018

Presentation TCT 2018

Case Presentation: Deterioration of LV Systolic Function/Worsened Heart Failure Despite Successful TMVR

Presenter: James B. Hermiller Jr, Wilson Y. Szeto, Khalil Fattouch, Sameer Gafoor, Adam B. Greenbaum, Roger J. Laham, Ruediger S. Lange, Rashmi Yadav

September 24, 2018

Presentation TCT 2018

Tendyne: Device Attributes, Implant Procedure, Clinical Results and SUMMIT Design and Status

Presenter: Michael J. Mack, David W.M. Muller, Gorav Ailawadi

September 24, 2018

Presentation TCT 2018

Intrepid: Device Attributes, Implant Procedure, Clinical Results, and APOLLO Design and Status

Presenter: Michael J. Mack, David W.M. Muller, Michael J. Reardon

September 24, 2018

Presentation TCT 2018

Should and Will COAPT Affect TMVR Trial Design and Patient Recruitment?

Presenter: David H. Adams, Shmuel Banai, Michael J. Mack

September 24, 2018

Presentation TCT 2018

Transcatheter Repair or Replacement for Secondary MR? Risk-Benefit Analysis

Presenter: David H. Adams, Shmuel Banai, Jason H. Rogers

September 24, 2018

Presentation TCT 2018

Adverse Outcomes in Early Feasibility TMVR Studies: Is it the Patient, the Device, or the Implant Technique?

Presenter: David H. Adams, Shmuel Banai, Molly Szerlip

September 24, 2018

Advertisement

Show me the Data: Key Clinical Trials of 2018

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

Structural Heart Disease Imagers Call for Greater Recognition, Focused Training

TCTMD’s Top 10 Most Popular Stories for September 2018

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

The Watch TAVR Trial: Rationale, Design and Status

A Patient With Atrial Fibrillation, Cryptogenic Stroke, and PFO: Watchman Despite OAC?

Addressing the Hurdles: Emerging Devices and Novel Valve Designs

The LAMPOON Procedure: Description and Clinical Outcomes

Case Presentation: Deterioration of LV Systolic Function/Worsened Heart Failure Despite Successful TMVR

Tendyne: Device Attributes, Implant Procedure, Clinical Results and SUMMIT Design and Status

Intrepid: Device Attributes, Implant Procedure, Clinical Results, and APOLLO Design and Status

Should and Will COAPT Affect TMVR Trial Design and Patient Recruitment?

Transcatheter Repair or Replacement for Secondary MR? Risk-Benefit Analysis

Adverse Outcomes in Early Feasibility TMVR Studies: Is it the Patient, the Device, or the Implant Technique?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content